Multicentre Longitudinal Study of the Prescription of Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Latest Information Update: 14 Jul 2022
At a glance
- Drugs Dexamethasone (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- Acronyms Louvre 2
- Sponsors Allergan
- 08 Jul 2022 Results published in the Ophthalmology and Therapy
- 31 Jul 2019 Status changed from recruiting to discontinued.
- 06 Aug 2018 Planned End Date changed from 1 Jan 2019 to 31 Oct 2020.